Nargenicin
Nargenicin is a macrolide antibiotic that is produced by the bacterium Nocardia argentinensis. It is known for its potent antibacterial activity against a wide range of Gram-positive bacteria, including drug-resistant strains such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).
History
Nargenicin was first isolated from Nocardia argentinensis in the 1970s. Since then, it has been the subject of numerous studies due to its potent antibacterial activity and unique mechanism of action.
Structure and Mechanism of Action
Nargenicin is a 16-membered macrolide antibiotic. Its structure is characterized by a large macrocyclic lactone ring, to which various sugar moieties are attached. This complex structure is believed to be responsible for its potent antibacterial activity.
The exact mechanism of action of nargenicin is not fully understood. However, it is believed to inhibit protein synthesis in bacteria by binding to the 50S ribosomal subunit, thereby preventing the translocation of peptidyl-tRNA from the A-site to the P-site of the ribosome.
Clinical Use
Despite its potent antibacterial activity, nargenicin is not currently used in clinical practice. This is primarily due to its poor solubility and stability, which make it difficult to formulate into a suitable dosage form. However, research is ongoing to develop new formulations of nargenicin that overcome these limitations.
Research and Development
In recent years, there has been renewed interest in nargenicin due to the increasing prevalence of drug-resistant bacteria. Several studies have shown that nargenicin is active against a wide range of drug-resistant bacteria, including MRSA and VRE. This has led to the suggestion that nargenicin could be used as a last-resort treatment for infections caused by these bacteria.
In addition to its antibacterial activity, nargenicin has also been shown to have anticancer activity. This has led to the suggestion that it could be used as a novel anticancer agent.
See Also
| This article is a stub. You can help WikiMD by registering to expand it. |
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD